Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease: An Open Label Extension (OLE) Study

NCT04799418 is registered in ClinicalTrials.gov with Scion NeuroStim as lead sponsor.

NCT NCT04799418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease: An Open Label Extension (OLE) Study
Lead sponsor
Scion NeuroStim
Phase
Not applicable
Overall status
Terminated
Start date
September 15, 2022
Completion date
February 24, 2025
Enrollment
148 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, parkinson's disease and parkinsonism